Navigating the complex landscape of legal procurement for controlled substances, specifically Schedule I drugs, represents a particularly niche area for licensed Canadian institutions—typically scientific facilities—and demands meticulous adherence to strict regulations. The process goes far beyond standard vendor selection, encompassing detail